Quest PharmaTech, Inc.
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- Public
- Established
- 1996-01-01
- Employees
- 1
- Market Cap
- -
A Controlled Study of the Effectiveness of Oregovomab (Antibody) Plus Chemotherapy in Advanced Ovarian Cancer
Phase 2
Completed
- Conditions
- Ovarian Neoplasms
- Interventions
- First Posted Date
- 2012-06-11
- Last Posted Date
- 2020-09-14
- Lead Sponsor
- Quest PharmaTech Inc.
- Target Recruit Count
- 97
- Registration Number
- NCT01616303
- Locations
- 🇺🇸
University of Connecticut Health Center, Farmington, Connecticut, United States
🇺🇸Northern Indiana Cancer Research Consortium, South Bend, Indiana, United States
© Copyright 2025. All Rights Reserved by MedPath